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Hrs
ESCRT
HCVThe molecular mechanisms of assembly and budding of hepatitis C virus (HCV) remain poorly understood.
The budding of several enveloped viruses requires an endosomal sorting complex required for transport
(ESCRT), which is part of the cellular machinery used to form multivesicular bodies (MVBs). Here, we dem-
onstrated that Hrs, an ESCRT-0 component, is critical for the budding of HCV through the exosomal secretion
pathway. Hrs depletion caused reduced exosome production, which paralleled with the decrease of HCV rep-
lication in the host cell, and that in the culture supernatant. Sucrose-density gradient separation of the cul-
ture supernatant of HCV-infected cells revealed the co-existence of HCV core proteins and the exosome
marker. Furthermore, both the core protein and an envelope protein of HCV were detected in the intralum-
inal vesicles of MVBs. These results suggested that HCV secretion from host cells requires Hrs-dependent exo-
somal pathway in which the viral assembly is also involved.
© 2011 Elsevier Inc. All rights reserved.Introduction
Hepatitis C virus (HCV) is a major cause of chronic liver disease,
with about 170 million people infected worldwide. It is important to
identify the molecular basis of HCV infection, propagation, and path-
ogenesis in humans. HCV is a positive-strand RNA virus belonging to
the Flaviviridae family and the sole member of the genus Hepacivirus.
The HCV RNA genome serves as a template for viral replication and as
a messenger RNA for viral production. It is translated into a single im-
mature polyprotein of approximately ~3000 amino acids that is fur-
ther cleaved into at least 10 mature proteins by proteases (Asselah
et al., 2009).
The HCV life cycle starts with virion attachment, especially
through its envelope glycoproteins E1 and E2, to speciﬁc receptors
on the host cells, which include CD81, claudin-1, and the class B
member I scavenger receptor (Evans et al., 2007; Murray et al.,ndosomal sorting complex re-
human herpes virus-6; HIV,
sicle L-domain, late-domain;
and Therapeutics, Miyagi Can-
a-Shiode, Natori, Miyagi, 981-
a).
rights reserved.2008). These receptors and co-receptors are also required for HCV
entry, which involves an additional clathrin-mediated post-
internalization step and delivery into early endosomes (Burlone and
Budkowska, 2009). Recently, the complete replication of HCV in a
cell culture system was achieved (Wakita et al., 2005). Nevertheless,
little is known about how the assembled HCV virion is released
from the cytoplasm.
Extensive research on human immunodeﬁciency virus (HIV) has
shown that the ESCRT (endosomal sorting complex required for
transport) machinery plays a crucial role in virion assembly and bud-
ding from cellular membranes: The late-domain (L-domain) motif of
HIV-Gag binds TSG101 (an ESCRT-I component) and Alix (a protein
that bridges ESCRT-I and ESCRT-III). Virion assembly, budding, and
release are subsequently achieved with help from the sequential
downstream ESCRT machinery (Chen and Lamb, 2008). Other envel-
oped viruses, such as hepatitis B virus and human T-cell leukemia
virus type I, also hijack the cellular membrane trafﬁcking and sorting
networks to accumulate and assemble their viral components, after
which the nascent virions pinch themselves off for release (Chen
and Lamb, 2008).
Similar to an enveloped virus particle that buds from the host-cell
surface, small vesicles, called exosomes, are physiologically secreted
from a variety of cells (Denzer et al., 2000; van Niel et al., 2006). Exo-
somes are nanovesicles (60–90 nm in diameter) surrounded by a
378 K. Tamai et al. / Virology 422 (2012) 377–385lipid bilayer. They are generated as intraluminal vesicles (ILVs) within
a sorting endosome called a multivesicular body (MVB), by the in-
ward budding of the MVB's limiting membrane. Exosome release
into the extracellular milieu is achieved by direct fusion of the MVB
with the plasma membrane (Pan et al., 1985).1.1
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Fig. 1. Localization of HCV protein to exosome-rich fractions. (A) Dot blot analysis of the sup
for an exosome protein (CD63) and HCV core protein. Huh7 cells were uninfected or infect
then incubated for 2 days, and the culture supernatants were harvested and puriﬁed by ultr
HCV and Lactate dehydrogenase was quantitated in culture supernatants. (C) HCV-RNA in
from infected and uninfected Huh7 cells, measured using real-time PCR. Puriﬁed exosome
not detectable. (D) Upper panel: Confocal microscopic image of Huh7 cells infected with JF
were partially colocalized. Lower panel: anti-core protein (green) and Mitotracker (red) w
Huh7 cells. Sections of Huh7 cells were incubated with antibodies against HCV core protein (
tein E2 (5-nm in F). Insets show a higher magniﬁcation. Bars: 200 nm, bars in insets: 50 nm.
protein (10 nm) and anti-CD63 (5 nm). Insets show a higher magniﬁcation. Bars: 200 nm,The sorting of ubiquitinated proteins on MVBs is mediated by the
ESCRT pathway. The ﬁrst complex that binds the cargo on endosomes
is ESCRT-0 which includes Hrs (Asao et al., 1997; Komada and
Kitamura, 1995) and STAMs, and with the help of ESCRTs-I, -II, and
-III, the cargo accumulates on the endosomal membrane. At the end1.1
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ed with JFH-1 (MOI=0.01), and the medium was changed after 3 days. The cells were
acentrifugations. (B) Huh7 cells were infected at a multiplicity of infection of 0.01 with
the culture supernatant at day 5 post-infection after infection with puriﬁed exosomes
s were obtained from 10 ml of supernatant of Huh7 cells at day 5 post-infection. N.D.,
H-1. The exosome and MVB marker, N-Rh-PE (red) and the HCV core protein (green)
ere used. Bar, 20 μm. (E and F) Immunoelectron microscopy of an MVB in wild-type
5-nm-colloidal-immunogold-labeled anti-mouse goat IgG in E) and HCV envelope pro-
(G) Double-staining of immunoelectron microscopy using antibodies against HCV core
bars in insets: 50 nm.
379K. Tamai et al. / Virology 422 (2012) 377–385of sorting, an AAA-type ATPase, VPS4, disrupts the ESCRT complexes,
and the membrane with its accumulated cargo is invaginated into the
maturing endosome to produce an MVB. A deﬁciency of Hrs results in
abnormally enlarged endosomes and a marked reduction in cargo
sorting to MVBs. The enlarged endosomes accumulate ligand-
activated membrane-bound growth factor receptors (Tanaka et al.,
2008). In this context, we recently demonstrated that Hrs is also re-
quired in dendritic cells for exosome secretion and antigen presenta-
tion via exosomes (Tamai et al., 2010).
Relationships are also reported between membrane trafﬁcking
and the HCV life cycle. ESCRT-III contributes to HCV release in Huh7
cells (Ariumi et al., 2011; Corless et al., 2010), as does transfection
of these cells with RNAi against Atg7, an essential autophagy gene
(Tanida et al., 2009). Another study suggested that human plasma
contains exosomes and that in HCV patients, viral RNA is associated
with these circulating vesicle (Masciopinto et al., 2004). Since Hrs,
an ESCRT-0 component, is involved in the autophagic pathway
(Tamai et al., 2007) and required for exosome secretion, we hypoth-
esized that Hrs plays a role in the HCV life cycle. Here we demonstrat-
ed that the Hrs-dependent exosomal pathway plays an important role
in HCV release.
Results
HCV core protein localizes to exosome-rich fractions
A relationship between virus production and the exosome path-
way has been suggested for HIV and human herpes virus 6 (HHV6)
(Lenassi et al.; Mori et al., 2008). We suspected that HCV also utilizes
the exosome pathway for its release from host cells. To examine this
possibility, we subjected the culture supernatants of HCV JFH-1-
infected Huh7 cells to sucrose density gradient centrifugation and an-
alyzed the fractions for exosomes and HCV. Interestingly, the identical
fractions were positive both for the exosomemarker CD63 and for theCo
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Fig. 2. Establishment of Huh7 lines with knocked-down Hrs, AMSH or Rab27a, and overexpre
AMSH (C) knock-down Huh7 cells. (B) Flow-cytometry analysis of Huh7 cells overexpressing
real-time PCR analysis of Rab27a in Huh7 cells. Rab27a mRNA expression was normalized tHCV core protein (Fig. 1A). Notably, more CD63-positive exosomes
were found in the HCV-infected Huh7 cells than in uninfected cells.
To exclude a possibility that the cytopathic effect (CPE) induced by
the infection of JFH-1 affects the amount of CD63 in the supernatant,
we monitored the CPE by the lactate dehydrogenase (LDH) assay. In
Huh7 cells, we observed slight increase of LDH at post-infection day
5 (Fig. 1B). As a positive control, we also investigated the CPE in
Huh7.5.1, which is more susceptible to JFH-1 infection. LDH level
was approximately two-times higher in this Huh7.5.1 cells than the
non-infected, which is compatible with a previous report (Shiina
and Rehermann, 2008). Puriﬁed exosomes from the culture superna-
tant of JFH-1-infected Huh7 cells possessed HCV-infectivity to Huh7
cells (Fig. 1C). These results indicated that the exosome secretion
was mainly activated during HCV infection.
We next addressed whether HCV localizes to the intraluminal
vesicles within the MVBs of JFH-1-infected Huh7 cells. Using confo-
cal microscopy, we found that N-Rh-PE-positive dots (an exosome
and MVB marker) were likely to colocalize with HCV-core-positive
dots (Fig. 1D, upper panels). As a negative control, immunoﬂuores-
cence staining was performed with anti-HCV-core and mitochondri-
al marker (Mitotracker (Molecular Probes)), which reportedly do
not colocalize with each other (Lai et al., 2010). We did observe
that HCV-core protein was not colocalized to mitochondria
(Fig. 1D, lower panels). By immunoelectron microscopy, we
detected positive immunogold staining for the HCV core antigen
on the intraluminal vesicles (Fig. 1E). Similarly, positive immuno-
gold staining for the HCV envelope protein E2 was observed on
intraluminal vesicles within MVBs (Fig. 1F). To make the relation-
ships between HCV particles and exosomes clearer, we performed
the double-staining of immunoelectron microscopy using anti-
CD63 and anti-core protein. We observed the colocalization of
CD63 and HCV-core in the intraluminal vesicles in the MVB
(Fig. 1G). These data together suggested that HCV virions and exo-
somes are present in the same or very similar compartments.No transfection
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ntr
ol
RN
Ai
FP
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GFP-fused VPS4B (wild-type and dominant-negative (E228Q) forms). (D) Quantitative
o GAPDH.
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Since Hrs is to be required for exosome secretion (Tamai et al.,
2010), we examined the roles of membrane trafﬁc-related proteins
in HCV secretion. For this study, we established an Hrs-depleted
Huh7 cell line using shRNA against human Hrs (Fig. 2A), and Huh7
cell lines that overexpressed wild-type VPS4B, and an ATPase-
negative VPS4B (VPS4BE228Q, Fig. 2B). We also prepared knock-
down Huh7 cell lines for AMSH, a deubiquitination enzyme that
binds the ESCRT-III complex, and for Rab27a, a Rab GTPase required
for exosome secretion, using speciﬁc shRNAs (Figs. 2C and D).
First, we conﬁrmed that Hrs plays a crucial role in exosome secre-
tion in Huh7 cells. Exosome secretion of the control Huh7 cells was
clearly increased by 48 h of stimulation with Ca2+ ionophore
A23187, a well-established stimulator for exosome secretion (Savina
et al., 2005), whereas a smaller increase was observed in the Hrs-
depleted Huh7 cells (Fig. 3). These data conﬁrmed Hrs's crucial role
in the exosome secretion of Huh7 cells.
Next, using the various Huh7 cell lines, we analyzed whether
membrane-trafﬁc-related proteins are involved in HCV release. We
ﬁrst compared the amount of HCV-RNA in the culture supernatants of
the Huh7 cell lines. The amount of HCV-RNA was signiﬁcantly lower
in the supernatant of the Hrs-depleted cells from days 3 to 5 post-
infection (Fig. 4A). Similarly, overexpression of the dominant-negative
VPS4B decreased the HCV-RNA production in Huh7 cells (Fig. 4B), con-
sistent with a previous report (Corless et al., 2010). In contrast, there
was no difference in the HCV release between the AMSH-depleted
and control Huh7 cells (Fig. 4C). However, HCV-RNA was dramatically
decreased in the Rab27a-depleted Huh7 cells (Fig. 4D).
We also conﬁrmed the amount of HCV by measuring the HCV in-
fectious titer in the supernatant. The virus titer was signiﬁcantly de-
creased in the absence of Hrs, Rab27a and overexpressed ATPase
defective-VPS4B, but not in the absence of AMSH (Fig. 4E). These
data were compatible with the amount of HCV-RNA.
Since Hrs-depletion decreased the Huh7 cells' growth rate (data
not shown), we also examined the amount of HCV using X-ray-
irradiated cells to inhibit the cell proliferation, and eliminate the cell
growth effect. In a preliminary experiment, we conﬁrmed that irradi-
ation with X-rays (25 Gy) was enough to inhibit the Huh7 cell prolif-
eration completely (data not shown). The amount of HCV-RNA in the
supernatant was decreased in the Hrs-depleted irradiated Huh7 cells
compared with control cells (Fig. 5). These data together indicated
that Hrs plays a crucial role in HCV secretion.
Analysis of intracellular HCV-RNA
We next assessed whether the decreased HCV release observed in
the Huh7 cell lines reﬂected a decrease in viral reproduction, byA23187
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Fig. 3. Hrs affects exosome release in Huh7 cells. Measurement of exosomes under
stimulation with a Ca2+ ionophore (A23187), using a protein assay. Control and Hrs-
knock-down Huh7 cells were incubated with 1 μM A23187 for 48 h.examining the intracellular HCV-RNA. In the Hrs-depleted Huh7
cells, no signiﬁcant decrease in the amount of intracellular HCV-
RNA was found (Fig. 6A). Similar results were obtained in the Huh7
cells expressing dominant-negative VPS4B and those with AMSH-
depletion (Figs. 6B and C). In the Rab27a-depleted Huh7 cells, the
amount of intracellular HCV-RNA was decreased on day 5. (Fig. 6D).
Next, we quantiﬁed the amount of intracellular HCV core protein
using Western blot analysis. The expression of core protein was al-
most the same between in the Hrs-depleted Huh7 cells and the con-
trol cells on days 5 and 7 post-infection (Fig. 6E). These results
suggested that Hrs is not involved in HCV replication or translation.
Since the HCV-RNA in the supernatant was decreased in Hrs-
depleted Huh7 cells without any decrease in the intracellular HCV-
RNA or core protein, the assembly and/or release of HCVmight be im-
paired in the absence of Hrs. Hence, we examined the effect of Hrs de-
pletion on the amount of intracellular infectious HCV particles by
performing a focus-forming unit assay. Intracellular infectious HCV
particles were decreased in Huh7 cells with Hrs-depletion and
Rab27a-depletion and those expressing dominant-negative VPS4B
compared with control cells on day 5 post-infection (Figs. 6F to I).
These data suggested that Hrs is required at least for HCV assembly.
Discussion
This study addressed the relationship between the ESCRT machin-
ery and HCV viral release. Although the initial studies on ESCRT pro-
teins mostly focused on their role in the endosomal sorting and
lysosomal digestion of membrane-bound receptors, there is accumu-
lating evidence that they also play important roles in MVB formation
(Wollert and Hurley, 2010). ESCRT executes scission of the endoso-
mal limiting membranes to form the intraluminal vesicles that char-
acterize MVBs and of the plasma membrane to release intraluminal
microvesicles into the extracellular environment as exosomes (de
Gassart et al., 2004). Here we demonstrated that an ESCRT-0 compo-
nent, Hrs, is crucial for HCV release through the exosome secretion
pathway.
Previous reports suggested that Hrs recruits ESCRT-I complex
components, including Tsg101, VPS28, and VPS37, and initiates the
ESCRT pathway. The ESCRT-I component Tsg101 was also reported
to form a complex with HIV-1 Gag, which promotes an Hrs-
independent ESCRT mechanism for HIV release (Pornillos et al.,
2003). Similarly, Tsg101 is involved in the release of human T-cell
leukemia virus (HTLV)-I, because Tsg101 depletion inhibits HTLV-I
budding (Blot et al., 2004). These viruses utilize not only ESCRT-I
but also its downstream machinery, including ESCRT-III and VPS4.
This is also the case for HCV, because ESCRT proteins such as ESCRT-
III, VPS4, TSG101, and Alix contribute to HCV release (Ariumi et al.,
2011; Corless et al., 2010). In this context, VPS4 is one of the last
and most potent molecules in the ESCRT pathway, and the depen-
dence of enveloped-virus budding on the ESCRT machinery has
been proved in several cases by showing that the budding is VPS4-
dependent. Taking all these data together, we concluded that HCV
takes advantage of the entire ESCRT machinery for its release.
In this study, Hrs depletion attenuated both HCV release into the
supernatant and the amount of infectious particles in the cytoplasm,
but not the amount of HCV-RNA in the cytoplasm, suggesting that
Hrs is involved in HCV assembly. A previous study suggested that
the formation of HCV virions is closely connected to lipid droplets
and the endoplasmic reticulum (ER) (Miyanari et al., 2007). Here
we observed two HCV antigens, the core protein and E2, within
MVBs in Huh7 cells, indicating that HCV probably takes advantage
of the MVBs themselves for its assembly. In this study, AMSH, which
does not affect MVB formation (data not shown), was not required
for HCV release, supporting our hypothesis. The relationship between
the ER and MVBs is not fully understood, but a recent study suggested
that direct membrane contact occurs between them (Eden et al.,
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Fig. 4. Hrs, VPS4B, and Rab27a, but not AMSH, affect HCV release. (A to D) HCV-RNA in the culture supernatant on the indicated day after infection, measured using real-time PCR.
Huh7 cells were infected with HCV (MOI=0.01). (E) Infectious HCV particles in the supernatant were measured by a focus-forming unit assay at day 5 post-infection.
381K. Tamai et al. / Virology 422 (2012) 377–3852010). Although the detailed mechanisms are not fully elucidated, we
propose that normal trafﬁcking via MVBs is required for the forma-
tion of complete HCV particles.
In this study we found the relationship between HCV and exo-
some from three experiments. First, by using immunoelectron mi-
croscopy, we demonstrated that HCV core protein and CD63
colocalized each other in MVB. Second, the confocal microscopy an-
alyses revealed that exosomal marker N-Rh-PE colocalized with the
core protein. Third, puriﬁed exosomal fraction possessed infectivity
to Huh7 cells. These results suggest that HCV particles indeed colo-
calize with exosomes, and contain exosome marker proteins. This
notion is not surprising because various viruses have been shown
to acquire parts of host cell-derived proteins (Kolegraff et al.,
2006). These phenomenons seem to reﬂect a fact that a number ofvirus carry host factors either during the assembly, or the release
from their respective host cells. In Fig. 1A, the peaks for the HCV
core protein and CD63 do not entirely correspond (1.18 g/ml and
1.15 g/ml, respectively). In general, HCV particles and exosomes in
diameter are very similar (50 nm and 30–100 nm, respectively). On
the other hand, HCV particles contain genomes which consist of a
positive-sense RNA molecule approximately 9.6 kb in length. It is
possible that the density of HCV particles is somewhat higher than
that of exosomes. Further study will be required to elucidate how
HCV particles and exosomes were similarly or differentially pro-
duced in MVB.
The detailed mechanisms by which HCV utilizes the ESCRT ma-
chinery for its release are still unknown. Capsid proteins of several vi-
ruses, such as HIV and HTLV-1 interact with ESCRT proteins via the
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382 K. Tamai et al. / Virology 422 (2012) 377–385capsid-proteins' L-domains. This interaction recruits ESCRT to the site
of capsid accumulation, and contributes to the budding of capsid-
captured membranes, scission, and the release of virions, using simi-
lar mechanisms to those involved in MVB formation (McDonald and
Martin-Serrano, 2009). Therefore, it is tempting to speculate a similar
viral structure-ESCRT interaction scenario for HCV release. However,
we found no canonical L-domains such as PT/SAP, YPXL, PPXY, or
LYPXnL, within the amino acid sequence of HCV proteins. In the
case of HIV-1, a previous report suggested that the HIV-1 Gag proteins
are ubiquitinated and that this ubiquitination is required for HIV-1 re-
lease (Gottwein and Krausslich, 2005). Concordantly, the HCV core
protein is reported to be ubiquitinated by E6AP (Shirakura et al.,
2007). Thus, the ESCRTs might interact with viral proteins through
the ESCRT proteins' ubiquitin-binding domain. Because Hrs possesses
two ubiquitin-binding regions, UIM and VHS, Hrs may recognize the
ubiquitinated HCV core proteins and sort them to the viral budding
site in the MVBs, thereby enabling virion release.3 5 7
Hrs-RNAi
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t experiments. (F to I) Intracellular infectious HCV particles were measured by a focus-
383K. Tamai et al. / Virology 422 (2012) 377–385A previous study suggested that human herpes virus-6 (HHV-6) is
released together with internal vesicles through MVBs by the cellular
exosomal pathway: HHV-6 undergoes maturation in the trans-Golgi
network (TGN) and post-TGN-derived vacuoles, which express an
exosomal marker, CD63, and MVBs contain HHV-6 envelope glyco-
proteins along with CD63 (Mori et al., 2008). In addition, HIV virions
released into the culture supernatant also contain CD63 (Gould et al.,
2003), and CD63-positive exosomes derived from HIV-infected cells
contain HIV Gag proteins (Booth et al., 2006). Here we showed that
CD63-positive exosomal fractions can also contain HCV particles.
Taken together, these observations support the idea that exosomal
secretion and the budding of HCV, HHV6, and HIV share overlapping
pathways.
Conclusion
Since we here provide evidence that Hrs is important in exosome
secretion and HCV release, Hrs may be one of the key players in HCV
release, through the exosomal pathway. Controlling this pathway
could become one of novel therapeutic strategies for chronic viral
infections.
Materials and methods
Ethics statements
This study was conducted according to the principles expressed in
the Declaration of Helsinki. The study was approved by the research
committees of the Miyagi Cancer Center and Tohoku University.
Cells
Huh7 and Huh7.5.1 (gift from Dr. Chisari, The Scripps Research In-
stitute, CA) cells were maintained in Dulbecco's modiﬁed essential
medium containing 10% fetal calf serum and antibiotics. To express
Hrs-speciﬁc short hairpin RNA (shRNA), a retroviral vector was gen-
erated as described previously (Tamai et al., 2007). In brief, a se-
quence encoding human Hrs-speciﬁc shRNA, was inserted into
pSIREN-RetroQ (BD Biosciences) to make pSIREN-RetroQ-Hrs. The
target sequence consisted of nucleotides 302–320 (5′-AGG-
TAAACGTCCGTAACAA-3′) of the human hrs cDNA. A control plasmid,
pSIREN-RetroQ-Luc, targeted bp 413–434 of ﬁreﬂy luciferase (5′-
GCAATAGTTCACGCTGAAAAG-3′). The retrovirus was prepared as
previously described (Tamai et al., 2007). A human AMSH-speciﬁc
short hairpin RNA (shRNA), pSIREN-RetroQ-AMSH, was also generat-
ed using pSIREN-RetroQ (Kyuuma et al., 2007). The target sequence
within the human AMSH cDNA was nucleotides 651–669 (5′-GCAG-
CAATTGGAACAGGAA-3′). A human Rab27a-speciﬁc shRNA lentiviral
vector was purchased from Sigma. LDH assay was performed accord-
ing to the manufacturer's protocol (Roche, Basel, Switzerland).
Isolation and puriﬁcation of exosomes
Exosomes were puriﬁed as previously described (Ostrowski et al.,
2010). In brief, the cell culture medium was centrifuged for 10 min at
300×g, 10 min at 1200×g, and 30 min at 10,000×g to remove cells
and debris. The supernatant obtained from the last spin was then cen-
trifuged for 60 min at 100,000×g, and the pellet was solubilized in
lysis buffer (1% Nonidet P-40, 20 mM Tris–HCl (pH 7.5), 150 mM
NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl ﬂuoride, and
20 μg/ml aprotinin) and analyzed by BCA protein assay (Pierce, Rock-
ford, IL, USA), according to the manufacturer's protocol. For sucrose
density gradient centrifugation, sucrose gradients were prepared
according to a former procedure (Abe and Davies, 1986). In brief,
5 ml 72% sucrose/PBS was overlaid with 5 ml 8.4% sucrose/PBS in
10 ml tubes, and the tubes stoppered and kept horizontal for 3 h atroom temperature, after which they were slowly returned to the up-
right position. The exosomal suspension was layered onto a gradient
sucrose and centrifuged at 100,000×g for 20 h in a Beckmann SW41Ti
rotor.
Western blotting
Immunoblotting was performed as described previously
(Takeuchi et al., 1999). In brief, total cell lysates were prepared with
NP-40-containing lysis buffer (described above). The lysates were
pre-cleared by centrifugation (10,000×g) for 20 min at 4 °C, and the
supernatants were separated by SDS-PAGE and transferred onto poly-
vinyl diﬂuoride (PVDF) membranes (Millipore). After being blocked
with 5% nonfat milk in Tris-buffered saline (TBS) containing 0.1%
Tween 20, the membranes were probed with the indicated primary
antibodies. After another wash, the membranes were probed with
HRP-conjugated secondary antibodies (Cell Signaling). For dot-blot
analyses, cell lysates were spotted onto PVDF membranes. The mem-
branes were blocked as described above and incubated with the indi-
cated antibodies.
Generation and quantiﬁcation of cell culture HCV RNA and infectious
titer
The HCV strain JFH-1 was a gift from Dr. T. Wakita (National Insti-
tute of Infectious Diseases, Japan) (Wakita et al., 2005). Cell-culture-
derived, infectious HCV was generated as described previously
(Wakita et al., 2005). The HCV was quantiﬁed as follows: RNA was
extracted from the Huh7 culture supernatant using the QIAamp
Viral RNA Kit (Qiagen, Valencia, CA). The HCV RNA was quantiﬁed
by real-time reverse transcription polymerase chain reaction using
TaqMan EZ RT-PCR Core Reagents (Applied Biosystems, Foster City,
CA), according to the manufacturer's protocol, using the published
primers and probe (Takeuchi et al., 1999). The ﬁltered (0.45 μm) cul-
ture supernatant of HCV-infected Huh-7.5.1 cells containing 2×108
HCV RNA copies/ml (equivalent to 9.7×104 focus-forming units
[ffu]/ml) was used for experiments. To analyze HCV-RNA in the su-
pernatant, Huh7 cells (2×105 cells in 6-well plate) were infected
with JFH-1 (multiplicity of infection, MOI=0.01), washed with PBS
twice after 4 h, the supernatants were collected, and the cells were
reseeded at 2×105 cells per 6-well plate at the indicated times.
Huh7 cells were irradiated with X-rays (25 Gy) before infection to ex-
clude the effect of cell proliferation in some experiments. To quantify
the intracellular HCV titer, infected Huh7 cells were harvested at the
indicated times and lysed by three freeze-thaw cycles. The virus titer
was determined by focus-forming unit assay, as previously described
(Kato et al., 2006).
Antibodies for immunoelectron microscopy
An anti-HCV-core mouse monoclonal antibody (mAb) (2H9, a gift
from Dr. Wakita, National Institute of Infectious Diseases, Japan) and
a human anti-E2 mAb (CBH5, a gift from Dr. Foung, Department of
Pathology, Stanford School of Medicine) were used as primary
antibodies. As secondary antibodies for immunoelectron microscopy,
5-nm-colloidal-immunogold-labeled anti-mouse goat IgG and 5-nm-
immunogold-labeled anti-human goat IgG antibodies (EY Laborato-
ries, San Mateo, CA) were used.
Quantitative real-time polymerase chain reaction
To conﬁrm the knock-down of Rab27a, quantitative real-time PCR
was performed. Total RNA was prepared from cells with the RNeasy
Mini kit (Qiagen). Complementary deoxyribonucleic acid (cDNA) was
synthesized using an oligo d(T)12–18primerwith a Primescript reverse
transcriptase (Takara Bio Inc, Japan) and subjected to quantitative real-
384 K. Tamai et al. / Virology 422 (2012) 377–385time PCR using a LightCycler 480 and the SYBR Green I Master kit
(Roche Diagnostics). The primer sequences were, for GAPDH,
5′-CTCTGCTCCTCCTGTTCGAC-3′ and 5′-GACAAGCTTCCCGTTCTCAG-3′;
and for Rab27a, 5′-TGGAGGACCAGAGAGTAGTGAAA-3′ and 5′-AGTTT-
CAAAGTAGGGGATTCCA-3′.
Phenotypic analysis of cells by ﬂow cytometry
Cells were assessed for VPS4B-GFP expression by ﬂuorescent mul-
ticolor ﬂow cytometry (FACSCantoII, Becton Dickinson, San Jose, CA)
as previously described (Tamai et al., 2010).
Immunoelectron microscopy
To analyze the localization of the HCV antigen in MVBs, Huh7 cells
infected with JFH-1 were ﬁxed with 1% glutaraldehyde in phosphate-
buffered saline (PBS, pH 7.2) at 4 °C for 2 h. The ﬁxed cells were
washed six times with PBS and dehydrated in a graded ethanol series.
The samples were then embedded in Lowicryl K4M resin (Poly-
science, Warrington, PA, USA), and allowed to polymerize in a UV ir-
radiator (DOSAKA EM, Kyoto, Japan) at−20 °C for 2 days and then at
room temperature for 2 days. Ultrathin sections were cut using an ul-
tramicrotome (Sorvall MT-5000, Du Pont, CT, USA) and mounted on a
nickel grid (300 mesh) supported by a carbon-coated collodion ﬁlm.
The ultrathin sections on the grid were treated with 5% normal goat
serum in PBS to block non-speciﬁc reactions. The sections were then
reacted with drops of primary antibody at 4 °C for 8 h, washed with
PBS, reacted with secondary antibody for 1 h at room temperature,
and washed again with PBS. The immunostained sections were ﬁxed
in 1% glutaraldehyde in PBS for 15 min and washed three times
with distilled water. Finally, the sections were subjected to contrast-
enhanced staining with 0.01% ruthenium red (Wako Pure Chemicals,
Osaka, Japan) and 0.5% osmium tetroxide in PBS at room temperature
for 10 min, further with 4%(w/v) uranyl acetate in distilled water for
15 min at room temperature, and observed under a transmission
electron microscope (H-7650, Hitachi, Tokyo, Japan).
For double-staining of immunoelectron microscopy, post-
embedding gold was carried out as described previously (Iwata et
al., 1995). Mouse anti-HCV-core IgG (2H9, diluted 50×) and rabbit
anti-CD63 IgG (sc-15363 Santa Cruz, diluted ×5) were used.
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